Mayne Pharma Group Ltd: 2024 AGM Chair's Address to Shareholders
Mayne Pharma Group Ltd: Mayne Pharma responds to media speculation
Mayne Pharma Group Ltd: Mayne Pharma to host interactive investor education webinar
Mayne Pharma Group Ltd: 2024 Corporate Governance Statement and Appendix 4G
Mayne Pharma Group Ltd: Mayne Pharma to present at HC Wainwright conference in NY
Mayne Pharma Group Ltd: Change of Director's Interest Notice
Mayne Pharma Group Ltd: Civil action against Mayne Pharma discontinued in Canada
Mayne Pharma Group Ltd: Notification of date for release of FY24 results
Mayne Pharma Group Ltd: MYX announces patent lawsuit against Sun Pharmaceutical
Mayne Pharma Group Ltd: Class action settlement
Mayne Pharma Group Ltd: Approval of additional KAPANOL dosages in Switzerland
Mayne Pharma Group Ltd: MYX to present at Jefferies Global Healthcare Conference
Mayne Pharma Group Ltd: Notification of buy-back - MYX
Mayne Pharma Group Ltd: Mayne Pharma Market Update
Mayne Pharma Group Ltd: MYX announces two additional patents for Nextstellis granted
Mayne Pharma Group Ltd: MYX to present at Citizens JMP Life Sciences Conference
Mayne Pharma Group Ltd: Notification of date for release of 1H24 results
Mayne Pharma Group Ltd: Notification of date for release of 1H24 results
Mayne Pharma Group Ltd: Mayne Pharma to present at JP Morgan Healthcare Conference
Mayne Pharma Group Ltd: Change of Director's Interest Notice
No Data
No Data